EQUITY (Tables)
|
12 Months Ended |
Dec. 31, 2024 |
Equity [Abstract] |
|
Reconciliation Of Common Stock Issued |
The following table reconciles common stock reported in the consolidated statements of changes in equity to the consolidated balance sheets.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
2024 |
|
2023 |
Common shares issued as reported in the consolidated statement of changes in equity |
|
231,295,639 |
|
|
229,785,241 |
|
Unissued retirement eligible restricted stock awards |
|
— |
|
|
4,125 |
|
Unvested restricted stock awards |
|
1,480,062 |
|
|
1,472,906 |
|
Unvested deferred stock awards issued |
|
1,996,058 |
|
|
2,448,904 |
|
Common shares issued as reported in the consolidated balance sheets |
|
234,771,759 |
|
|
233,711,176 |
|
|
Change in Noncontrolling Ownership Interest |
The following schedule reflects the change in ownership interests for these transactions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
2024 |
|
2023 |
|
2022 |
|
|
|
As Revised |
|
As Revised |
|
(in thousands) |
Net income attributable to common stockholders of Live Nation |
$ |
896,287 |
|
|
$ |
556,893 |
|
|
$ |
266,440 |
|
Transfers of noncontrolling interests: |
|
|
|
|
|
Changes in Live Nation’s additional paid-in capital for purchases of noncontrolling interests, net of transaction costs |
(30,049) |
|
|
(100,940) |
|
|
(64,601) |
|
Changes in Live Nation’s additional paid-in capital for sales of noncontrolling interests, net of transaction costs |
— |
|
|
— |
|
|
— |
|
Net transfers of noncontrolling interests |
(30,049) |
|
|
(100,940) |
|
|
(64,601) |
|
Change from net income attributable to common stockholders of Live Nation and net transfers of noncontrolling interests |
$ |
866,238 |
|
|
$ |
455,953 |
|
|
$ |
201,839 |
|
|
Schedule of Accumulated Other Comprehensive Income (Loss) |
The following table presents changes in the components of AOCI, net of taxes, for the years ended December 31, 2024, 2023 and 2022:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flow Hedges |
|
|
|
Foreign Currency Items |
|
|
|
Total |
|
|
|
|
|
|
As Revised |
|
|
|
As Revised |
|
|
(in thousands) |
Revised Balance at December 31, 2021 |
|
$ |
(8,558) |
|
|
|
|
$ |
(144,242) |
|
|
|
|
$ |
(152,800) |
|
Other comprehensive income before reclassifications |
|
49,529 |
|
|
|
|
12,883 |
|
|
|
|
62,412 |
|
Amount reclassified from AOCI |
|
312 |
|
|
|
|
— |
|
|
|
|
312 |
|
Net other comprehensive income |
|
49,841 |
|
|
|
|
12,883 |
|
|
|
|
62,724 |
|
Balance at December 31, 2022 |
|
41,283 |
|
|
|
|
(131,359) |
|
|
|
|
(90,076) |
|
Other comprehensive income before reclassifications |
|
5,225 |
|
|
|
|
129,459 |
|
|
|
|
134,684 |
|
Amount reclassified from AOCI |
|
(17,158) |
|
|
|
|
— |
|
|
|
|
(17,158) |
|
Net other comprehensive income (loss) |
|
(11,933) |
|
|
|
|
129,459 |
|
|
|
|
117,526 |
|
Balance at December 31, 2023 |
|
29,350 |
|
|
|
|
(1,900) |
|
|
|
|
27,450 |
|
Other comprehensive income (loss) before reclassifications |
|
10,529 |
|
|
|
|
(354,730) |
|
|
|
|
(344,201) |
|
Amount reclassified from AOCI |
|
(18,361) |
|
|
|
|
— |
|
|
|
|
(18,361) |
|
Net other comprehensive loss |
|
(7,832) |
|
|
|
|
(354,730) |
|
|
|
|
(362,562) |
|
Balance at December 31, 2024 |
|
$ |
21,518 |
|
|
|
|
$ |
(356,630) |
|
|
|
|
$ |
(335,112) |
|
|
Computation of Weighted Average Common Shares Outstanding |
The following table sets forth the computation of weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
2024 |
|
2023 |
|
2022 |
Weighted average common shares—basic |
|
230,124,255 |
|
|
228,628,390 |
|
|
224,809,558 |
|
Effect of dilutive shares: |
|
|
|
|
|
|
Stock options and restricted stock |
|
2,686,001 |
|
|
2,348,936 |
|
|
6,747,308 |
|
Convertible senior notes |
|
3,542,193 |
|
|
— |
|
|
— |
|
Weighted average common shares—diluted |
|
236,352,449 |
|
|
230,977,326 |
|
|
231,556,866 |
|
|
Potentially Dilutive Securities Excluded From Diluted Net Income Per Common Share |
The following table shows securities excluded from the calculation of diluted net income per common share because such securities were anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
2024 |
|
2023 |
|
2022 |
Options to purchase shares of common stock |
|
— |
|
|
3,750 |
|
|
3,750 |
|
Restricted and deferred stock awards—unvested |
|
1,518,940 |
|
|
2,527,463 |
|
|
2,218,563 |
|
|
|
|
|
|
|
|
Conversion shares related to convertible senior notes |
|
14,946,450 |
|
|
13,004,660 |
|
|
11,864,035 |
|
Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding |
|
16,465,390 |
|
|
15,535,873 |
|
|
14,086,348 |
|
|